Loading company details...
Beta
Latest Form 4 (Oct 16, 2026): Michael Marinaro (EVP, Pres MedSurg and Americas): Sale of 10,420 shares, $1.00M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Michael Marinaro, EVP, Pres MedSurg and Americas | Sale | 10,420 | $1.00M |
| Oct 16, 2026 | Geoffrey Martha, Chairman and CEO | Sale | 50,000 | $4.75M |
| Sep 17, 2026 | Harry Skip Kiil, EVP & President Cardiovascular | Sale | 1,483 | $138.9K |
| Sep 16, 2026 | Denise L. Blomquist, Chief Accounting Officer | Gift | 600 | n/a |
| Aug 24, 2026 | Michael Marinaro, EVP, Pres MedSurg and Americas | Tax Withholding | 1,084 | $100.1K |
| Aug 5, 2026 | Denise L. Blomquist, Chief Accounting Officer | Tax Withholding | 212 | $18.1K |
| Aug 5, 2026 | Matthew R. Walter, SVP, Chief HR Officer | Tax Withholding | 1,675 | $143.0K |
| Aug 4, 2026 | Kweli Thompson, EVP & President, Neuroscience | Tax Withholding | 1,739 | $148.5K |
| Aug 4, 2026 | Michelle Quinn, EVP, GC and Secretary | Grant/Award | 6,346 | n/a |
| Aug 4, 2026 | Thierry Pieton, EVP & Chief Financial Officer | Grant/Award | 11,537 | n/a |